We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 15

Medical diagnostic claims and Bilski
  • Gowling WLG
  • USA
  • September 6 2010

In the long awaited decision in Bilski v. Kappos, the U.S. Supreme Court has concluded that the machine-or-transformation (“MOT”) test is not the sole arbiter of patentable subject matter for “processes” under section 101 of the U.S. Patent Act.


Big pharma continues to woo biotech
  • Gowling WLG
  • USA
  • May 8 2008

Large pharmaceutical companies have continued their pursuit of biotech companies in 2008, maintaining a recent trend of big pharma looking to the biotech sector to find new products and technologies.


Decoded genome reveals greater genetic diversity
  • Gowling WLG
  • USA
  • September 13 2007

We are each more unique than originally thought.




Michael Crichton
  • Gowling WLG

Michael Herman
  • Gowling WLG


Wendy J. Wagner
  • Gowling WLG